​

Caribou Biosciences (CRBU) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Caribou Biosciences Revenue Highlights

0

Latest Revenue (Q)

$3.46M

Main Segment (Y)

Reportable Segment

Main Geography (Y)

UNITED STATES

Caribou Biosciences Revenue by Period

Caribou Biosciences Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$34.48M148.91%
2022-12-31$13.85M44.31%
2021-12-31$9.60M-22.35%
2020-12-31$12.36M113.56%
2019-12-31$5.79M-

Caribou Biosciences generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Caribou Biosciences Revenue by Quarter

DateRevenueChange
2024-06-30$3.46M42.61%
2024-03-31$2.43M-31.73%
2023-12-31$3.56M-84.96%
2023-09-30$23.66M530.15%
2023-06-30$3.75M7.22%
2023-03-31$3.50M-5.15%
2022-12-31$3.69M11.78%
2022-09-30$3.30M-21.21%
2022-06-30$4.19M57.36%
2022-03-31$2.66M4.10%
2021-12-31$2.56M-35.66%
2021-09-30$3.98M169.44%
2021-06-30$1.48M-6.94%
2021-03-31$1.59M61.18%
2020-12-31$984.00K-17.86%
2020-09-30$1.20M-85.87%
2020-06-30$8.48M398.41%
2020-03-31$1.70M-

Caribou Biosciences generated $3.46M in revenue during Q2 2024, up 42.61% compared to the previous quarter, and up 98.91% compared to the same period a year ago.

Caribou Biosciences Revenue Breakdown

Caribou Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$9.99M

Caribou Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Caribou Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21
UNITED STATES$9.27M$32.77M$13.30M$8.91M
Non-US$724.00K$1.71M$548.00K$685.00K

Caribou Biosciences's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (92.76%), and Non-US (7.24%).

Quarterly Revenue by Country

CountryDec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Non-US$197.00K$367.00K$160.00K$1.20M$9.00K$117.00K$150.00K$337.00K$9.00K$52.00K$129.00K--
UNITED STATES$5.34M$1.66M$2.27M$2.35M$3.75M$3.38M$3.54M$2.97M$4.18M$2.61M$2.43M$3.51M$1.48M
Non Us-----------$470.00K$111.00K

Caribou Biosciences's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (96.44%), and Non-US (3.56%).

Caribou Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADPTAdaptive Bio$178.96M$46.44M
CRSPCRISPR Therapeutics$37.31M$602.00K
VERVVerve Therapeutics$32.33M$6.87M
FATEFate Therapeutics$13.63M$6.77M
PRMEPrime Medicine$2.98M$39.31M
NTLAIntellia Therapeutics-$9.11M
EDITEditas Medicine--
SANASana Bio--
CRBUCaribou Biosciences-$3.46M
BEAMBeam Therapeutics-$14.27M

CRBU Revenue FAQ

What is Caribou Biosciences’s yearly revenue?

Caribou Biosciences's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $34.48M, representing an increase of 148.91% compared to 2022. CRBU's yearly revenue for 2022 was $13.85M, representing an increase of 44.31% compared to 2021.

What is Caribou Biosciences’s quarterly revenue?

Caribou Biosciences's quarterly revenue for Q2 2024 was $3.46M, a 42.61% increase from the previous quarter (Q1 2024), and a -7.75% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.43M, a -31.73% decrease from the previous quarter (Q4 2023), and a -30.64% decrease year-over-year (Q1 2023). CRBU's quarterly revenue for Q4 2023 was $3.56M, a -84.96% decrease from the previous quarter (Q3 2023), and a -3.63% decrease year-over-year (Q4 2022).

What is Caribou Biosciences’s revenue growth rate?

Caribou Biosciences's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Caribou Biosciences’s revenue streams?

Caribou Biosciences's revenue streams in c 24 are Reportable Segment

What is Caribou Biosciences’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Caribou Biosciences was Reportable Segment. This segment made a revenue of $9.99M, representing 100.00% of the company's total revenue.